LYPHOMED <LMED> TO MARKET ANTIBIOTIC
LyphoMed Inc said the Food and
Drug Administration gave it approval to market Vancomycin HCL,
an antibiotic used in hospitals to treat life-threatening
infections.
    It said the product is currently marketed by Eli Lilly and
Co <LLY> under the trade name Vancocin. Sales in 1986 were 110
mln dlrs.
    LyphoMed said its objective is to get a 15 to 20 pct share
of the market.
 Reuter
